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Abstract
Hospital-acquired acute kidney injury (HA-AKI) is a heterogeneous renal syndrome which occurs in different clinical settings. 
It is characterized by multiple aetiologies, various pathogeneses and unpredictable outcomes. HA-AKI, once predominantly 
viewed as a self-limited and reversible short-term condition, is now recognized as a harbinger for chronic kidney disease and 
a cause of long-term morbidity with an increased risk of cardiovascular, renal and cancer mortality. Recent clinical studies 
contradict the generally held belief that female sex is a risk factor for HA-AKI. They show, consistent with basic research 
performed with experimental models of AKI, that only male sex is associated with HA-AKI. The presence of testosterone, 
more likely than the absence of estrogen, plays a critical role in sex differences in the susceptibility of ischemia/reperfu-
sion kidney injury. The conflicting data in epidemiological studies related to sex as susceptibility variable for human AKI, 
underscore the need for more rigorous, well designed observational studies taking into account the menopausal status and 
hormone therapy.
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Introduction
Hospital-acquired acute kidney injury (HA-AKI) is a com-
plex clinical syndrome with multiple risk factors and aetiolo-
gies, a broad spectrum of clinical presentations and unpre-
dictable short-and long-term outcomes. Currently, treatment 
of established acute kidney injury (AKI) is mainly support-
ive in nature. No pharmacological intervention has shown 
efficacy to improve morbidity and mortality attributable to 
AKI. Identifying patients at high risk, awareness of prevent-
able AKI, early recognition and management of incipient 
AKI are key factors to reduce cases of established AKI and 
to improve the dismal outcome of severe AKI [1].
Observational studies have identified a variety of risk 
factors including pre-existing susceptibilities of individ-
ual patients in combination with the nature and severity 
of acute kidney insults. Sex differences are of fundamen-
tal importance in chronic kidney disease (CKD). Bio-
logical sex is increasingly recognized as modulator of the 
pathophysiology, disease development, progression and 
management of CKD. Male patients with proteinuric CKD 
have a faster progression of CKD to end-stage kidney dis-
ease (ESKD) than women with the same grade of proteinu-
ria, indicating that female sex may be reno-protective [2]. 
Sexual dimorphism has also been examined in HA-AKI. 
However, observational studies in humans reported con-
flicting findings [3] such as: (1) women have a greater risk 
for HA-AKI; (2) no association between sex and HA-AKI 
was found in subpopulations; (3) women exhibit a decreased 
susceptibility to HA-AKI.
This narrative review starts with a critical appraisal of 
published studies, and thereafter discusses the proposed sex 
hormone effects for the pathogenesis of HA-AKI and for the 
transition of AKI to CKD.
Sex and HA‑AKI
At present, there are no randomized controlled trials examin-
ing sex as a susceptibility variable for HA-AKI. Most clini-
cal cohort studies are confounded by the inclusion of women 
across all age groups including pre- and post-menopausal 
women in an uncontrolled way.
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Older epidemiologic studies focused on male-only or 
male-predominant populations claimed that female sex was 
associated with higher risk for AKI after cardiac surgery, 
contrast -induced nephropathy or drug-induced nephrotox-
icity. Consequently, female sex has been included as a risk 
factor in models developed to predict the risk of these AKI 
aetiologies [4]. The KDIGO (Kidney Disease Improving 
Global Outcomes) Practice guidelines stated that contrary 
to most CKDs, female sex was among the shared susceptibil-
ity factors that confer a high risk of HA-AKI [5]. Confound-
ing systematic bias and insufficient statistical power in these 
studies has resulted in the wrong assumption that female sex 
may enhance susceptibility for HA-AKI. However, it was 
generally assumed, that data obtained from research involv-
ing male subjects could be simply extrapolated to women, 
and therefore, there was apparently no need to include an 
adequate number of female subjects in clinical studies.
With the advent of guidance documents and USA federal 
law (1993 National Institute of Health Revitalization Act) 
for enrolment of women in clinical research, a new aware-
ness of the distinction between women and men evolved. 
Recently, Neugarten et al. analysed 28 studies from 2003 to 
2018 (6,758,124 patients; 2,313,202 women and 4,444,922 
men) that utilized multivariate analysis to asses risk factors 
for various aetiologies of HA-AKI and provided sex-strat-
ified odds ratios. The results of this meta-analysis demon-
strated that female sex is associated with protection against 
AKI and undermined the previously established belief that 
female sex is a significant risk factor for AKI. On the con-
trary male sex seems to enhance the susceptibility for HA-
AKI. Subgroup meta-analyses showed that male sex was 
associated with an increased risk in unselected hospitalised 
patients, in critically ill patients, and in patients undergo-
ing non-cardiac surgery. There was no association of sexual 
dimorphisms and post-cardiac surgery AKI and contrast-
induced nephropathy [6].
However, residual measured, and non-measured con-
founding persists when using large health data bases. Biases 
may influence not only the result of a well performed obser-
vational study but also the conclusions made by the authors 
of meta-analyses.
Existing big data of hospitalized patients may be incom-
plete, inaccurate or inconsistently measured, and may 
explain the failure to show an association of sexual dimor-
phism and specific aetiologies of HA-AKI.
The diagnosis of HA-AKI is currently guided by changes 
in serum creatinine, urine output, or both over time [5]. 
Thus, a major limitation of meta-analyses relates to the 
inherent difficulty to identify HA-AKI in men relative to 
women in the light of sex-related differences in creati-
nine kinetics. Current classification systems for AKI differ 
regarding the increases in serum creatinine levels and in the 
observation time necessary to detect threshold changes in 
serum creatinine levels. The sex-stratified incidence of HA-
AKI also varies according to the classification system used 
[7]. Srisawat et al. showed that the incidence of HA-AKI was 
greater in men than women when KDIGO criteria were used 
to define AKI, but that sex-related differences in HA-AKI 
disappeared when RIFLE criteria were used [8]. Consistent 
with these observations, the subgroup analysis by Neugarten 
et al. showed, that female sex was more likely associated 
with protection from AKI in those studies which utilized 
KDIGO criteria than in those that used RIFLE criteria [6].
Observational studies repeatedly demonstrated in unad-
justed analyses, that the incidence of contrast induced 
nephropathy (CIN) was greater in women than in men. 
However, procedural factors such as the total volume of 
contrast media or the type and osmolarity of contrast media 
are crucial for the development of CIN. The association of 
CIN incidence and female sex may merely reflect a higher 
dose of contrast media administered to women than to men. 
Women generally have lower body weights or body surface 
areas than men, and accordingly the volume of contrast 
media administered, when expressed as total volume or as 
volume per body surface area has frequently been reported 
to be higher in women than in men [9]. Numerous studies 
utilizing multivariate analysis found that the variable “sex” 
is not associated with CIN.
Different patient populations may be characterized by 
different risk factors that convey different levels of risk for 
HA-AKI [10, 11]. Postcardiac surgery AKI relates to multi-
ple patient-, acuity of the disease-, and surgical procedure-
related risk factors. Women undergoing cardiac surgery 
often have more comorbid conditions which may mask the 
female sex-related protection of HA-AKI [12].
A small cohort study with 35 patients fulfilling the strict 
diagnostic criteria for the systemic inflammatory response 
syndrome (SIRS), found that pre-menopausal women seem 
to be protected from both AKI and acute respiratory distress 
syndrome (ARDS) [13]. It has been demonstrated, that the 
lower susceptibility to HA-AKI in women may be lost in 
aged women [14, 15].
Sex and recovery of kidney function from HA‑AKI
Patients who survive HA-AKI have an increased risk for pro-
gressive CKD, depending on the nature, severity and dura-
tion of the acute renal dysfunction and the presence of pre-
existing CKD. Weinhandl et al. reported at the 2019 Kidney 
week conference of the American Society of Nephrology, 
that younger age, female sex and lower serum creatinine 
were among the demographic and biochemical variables 
most strongly associated with recovery of kidney function 
after initiation of outpatient haemodialysis for AKI in 12,221 
patients [16]. Female sex was significantly associated with 
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a 24% increased likelihood of recovering kidney function 
and a 14% decreased likelihood of transitioning to ESKD.
Sex and susceptibility of rodents to experimental 
AKI models
Experimental science is producing tantalizing clues that sex 
differences influence the susceptibility to AKI and the recov-
ery of renal function from AKI. Rodents (rats, mice) are 
genetically similar to humans, and are often used for experi-
mental models of AKI. These animal studies have repeatedly 
suggested that sexual hormones (testosterone, testosterone/
estrogen ratio, estrogen) are important determinants of sex 
differences in AKI susceptibility [17–23]. Female rodents 
(mice, rats) are much more resistant to ischemic renal injury 
when compared with male rodents. This protective effect 
of female sex has been consistently observed in models of 
ischemia–reperfusion (IR) injury, cardiac arrest/cardiopul-
monary resuscitation and endoplasmic reticulum stress-
induced kidney injury. Park et al. demonstrated that presence 
of testosterone, more than the absence of estrogen, induces 
kidney injury associated with IR [23]. Testosterone admin-
istration to female mice increased the kidney susceptibility 
to ischemia. Castration reduced IR induced kidney injury. In 
contrast, oophorectomy did not affect kidney injury induced 
by ischemia in female mice. Patil et al. tested the hypothesis 
that different levels of testosterone promote renal IR [24]. 
Their data suggested that the in contrast to acute high doses 
of testosterone, acute low dose testosterone was protective 
against IR AKI in male rats due to its effects on inflamma-
tion by reducing renal T cell infiltration and by shifting the 
balance in favour of anti-inflammatory cytokines.
Experiments involving rats found that there was a sexual 
dimorphism in the post-ischemic AKI to CKD transition 
and the reno-protection observed with female rats was lost 
with oophorectomy. The authors concluded that female sex 
hormones were responsible for the reno-protection observed. 
Early antioxidant defence and higher TGFβ, HIF1α and 
eNOS were among the reno-protective mechanisms that 
were demonstrated in female rats after IR [21].
Recent advances have led to a greater appreciation of how 
mitochondrial dysfunction contributes to the pathogenesis of 
ischemic or septic AKI, from decreased ATP production, to 
enhanced mitochondrial oxidative stress, cell necrosis and 
apoptosis. There are important sex hormone-related differ-
ences in mitochondrial respiration, biogenesis and dynamics 
[22].
However, it is important to be cautious when interpret-
ing pathophysiologic findings and therapeutic interven-
tions derived from the existing animal models of AKI. The 
development of animal models that manifest comorbid fac-
tors commonly known to affect the immune response and 
increase the risk of AKI is imperative to increase the clinical 
applicability of such observations. Current models of septic 
AKI do not reproducibly result in kidney injury. The absence 
of sepsis-related comorbidities is also a limiting factor that 
needs to be considered when translating findings derived 
from experimental AKI models to humans.
Finally, little is known about the cellular and molecular 
mechanisms underlying these sex differences in experimen-
tal models of AKI (Fig. 1).
Conclusions
Experimental models of AKI clearly show a deleterious 
effect of testosterone and a protective effect of estrogen, 
but the data in humans are less clear. The conflicting epi-
demiologic data underscore the need for more rigorous, 
well designed, observational studies. These studies should 
adjust for the menopausal status and the history of hormone 
therapy.
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Fig. 1  Putative mediators of the impact of sex on acute kidney dis-
ease
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